Showing results (81-90 of 259) with videos related to
Sort By:
Pageof 26
Annals of Hematology|May 9, 2020
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myelomaXiao Ding, Wenyang Huang, Yi Peng, et al.International Journal of Hematology|April 26, 2017
The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective studyShuhua Yi, Heng Li, Zengjun Li, et al.Haematologica|July 2, 2026
The prognostic implications of autoimmune hemolytic anemia in chronic lymphocytic leukemia across treatment erasYuting Yan, Yongxin Xia, Rui Cui, et al.Cancers|September 9, 2022
Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple MyelomaYihui Wang, Qin Yang, Yinghong Zhu, et al.International Journal of Cancer|May 5, 2026
Late and Durable Minimal Residual Disease Response Predicts Favorable Outcomes in Newly Diagnosed Multiple MyelomaJieqiong Zhou, Wenqiang Yan, Yuntong Liu, et al.Theranostics|December 8, 2016
Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple MyelomaMridul Roy, Long Liang, Xiaojuan Xiao, et al.British Journal of Haematology|February 9, 2023
Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenaseJingyu Zhang, Fangming Shi, Xing Liu, et al.Annals of Hematology|October 27, 2022
Safety and efficacy of daratumumab in Chinese patients with relapsed or refractory multiple myeloma: a phase 1, dose-escalation study (MMY1003)Hongmei Jing, Li Yang, Junyuan Qi, et al.Clinical Lymphoma, Myeloma & Leukemia|March 30, 2020
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 CasesYuting Yan, Rui Lv, Wenjie Xiong, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 3, 2015
[The impact of renal function on prognostic value of β₂-microglobulin of ISS stage system in multiple myeloma patients--Clinical data analysis of 666 patients in a single center]Xiaoqi Qin, Yan Xu, Gang An, et al.Pageof 26